Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Chiral Technologies
Chiral Technologies
Activities:
Manufacturing
Research & Development
Analysis
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Manufacturing
Chiral Technologies promotes Joseph Barendt to President
For the past decade he has been Chief Operating Officer at the enantioselective chromatography specialist
Manufacturing
Chiral Technologies buys Diffinity Genomics
Diffinity Genomics has developed novel technology for the purification of nucleic acids
Manufacturing
Chiral Technologies introduces Chiralflash liquid chromatography columns
MPLC columns are packed with immobilised chiral stationary phases
Analysis
Chiral Technologies introduces technology for separating free amino acids
Chiralpak Zwix (+) and Chiralpak Zwix (-) exhibit stereoselectivity for zwitterionic molecules
Chiral Technologies introduces chiral stationary phase
Chiralpak ID is the fourth addition to the family
Manufacturing
Chiral Technologies gains rights to CSPs
Signs exclusive agreement with University of Vienna
Subscribe now